5-[4-(4-(2-AMINO-2 METHOXYCARBONYLETHYL)PHENOXY)BENZILIDENE]THIAZOLIDIN-2,4-DIONE DERIVATIVES AND RELATED COMPOUNDS FOR REDUCING GLUCOSE, CHOLESTEROL AND TRIGLYCERIDE LEVELS IN PLASMA

Diphenyl ether compounds of the formula (I) are provided th-it exhibit activity useful for reducing glucose, cholesterol, and/or triglyceride levels in plasma, and for treatment of obesity, inflammation, immunological diseases, autoimmune diseases, diabetes and disorders associated with insulin resi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: AGARWAL, SHIV KUMAR, BADIGER, SANGAMESH, NAG, ABHIJEET, NEOGI, PARTHA, NAG, BISHWAJIT, DEY, DEBENDRANATH, REDDY, GADDAM OM, PANDEY, SURENDRA KUMAR, SINGH, GAJENDRA, CHITHRA, SANTHANAGOPALAN
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator AGARWAL, SHIV KUMAR
BADIGER, SANGAMESH
NAG, ABHIJEET
NEOGI, PARTHA
NAG, BISHWAJIT
DEY, DEBENDRANATH
REDDY, GADDAM OM
PANDEY, SURENDRA KUMAR
SINGH, GAJENDRA
CHITHRA, SANTHANAGOPALAN
description Diphenyl ether compounds of the formula (I) are provided th-it exhibit activity useful for reducing glucose, cholesterol, and/or triglyceride levels in plasma, and for treatment of obesity, inflammation, immunological diseases, autoimmune diseases, diabetes and disorders associated with insulin resistance. (I) wherein represents an optional bond; W represents O or S; Z represents CR10, O or S; G represents O, S or together with R10 forms a 5 or 6 membered aromatic or heteroaromatic ring system containing 1 or 2 heteroatoms selected from the group consisting of O, S and N; R8 represents OR13 or NR14R15; where R13 is selected from the group consisting of hydrogen, substituted and unsubstituted (C1-C20) alkyl, (C2-C20) alkenyl, (C5-C14) aryl, (C6-C34) aralkyl, (C1C13) heteroaryl, and a counter ion; and where R14 and R15 are independently selected from the group consisting of H, substituted and unsubstituted (C1-C20) alkyl, (C2-C20) alkenyl and (C5-C14) aryl; the other substituents are defined in the claims.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2598087C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2598087C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2598087C3</originalsourceid><addsrcrecordid>eNqFjMFKA0EQRPfiQdRvsI8GMiBrQpLjZKaz29DbvczMLtmIhCDjSTQQ_83fcxDvQkFRj6q6rr6X5nlhHopqYzsSNTV0mFrdT86GrcrEJU0861uUAmdblAMxeRR8SS3Zg5ZAYur5wnhSQfAYaLSJRoxgxUNAtgk9OO16HcRH2Gko1A-OpIGGB6cR5-BaZYwJg_LvLgVqeHLlzSMwjsgRSKBnGzt7W129nd4v-e7Pb6r7HSbXmnz-PObL-fSaP_LX0dl6uVk_rlfu6f_GD43mSkQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>5-[4-(4-(2-AMINO-2 METHOXYCARBONYLETHYL)PHENOXY)BENZILIDENE]THIAZOLIDIN-2,4-DIONE DERIVATIVES AND RELATED COMPOUNDS FOR REDUCING GLUCOSE, CHOLESTEROL AND TRIGLYCERIDE LEVELS IN PLASMA</title><source>esp@cenet</source><creator>AGARWAL, SHIV KUMAR ; BADIGER, SANGAMESH ; NAG, ABHIJEET ; NEOGI, PARTHA ; NAG, BISHWAJIT ; DEY, DEBENDRANATH ; REDDY, GADDAM OM ; PANDEY, SURENDRA KUMAR ; SINGH, GAJENDRA ; CHITHRA, SANTHANAGOPALAN</creator><creatorcontrib>AGARWAL, SHIV KUMAR ; BADIGER, SANGAMESH ; NAG, ABHIJEET ; NEOGI, PARTHA ; NAG, BISHWAJIT ; DEY, DEBENDRANATH ; REDDY, GADDAM OM ; PANDEY, SURENDRA KUMAR ; SINGH, GAJENDRA ; CHITHRA, SANTHANAGOPALAN</creatorcontrib><description>Diphenyl ether compounds of the formula (I) are provided th-it exhibit activity useful for reducing glucose, cholesterol, and/or triglyceride levels in plasma, and for treatment of obesity, inflammation, immunological diseases, autoimmune diseases, diabetes and disorders associated with insulin resistance. (I) wherein represents an optional bond; W represents O or S; Z represents CR10, O or S; G represents O, S or together with R10 forms a 5 or 6 membered aromatic or heteroaromatic ring system containing 1 or 2 heteroatoms selected from the group consisting of O, S and N; R8 represents OR13 or NR14R15; where R13 is selected from the group consisting of hydrogen, substituted and unsubstituted (C1-C20) alkyl, (C2-C20) alkenyl, (C5-C14) aryl, (C6-C34) aralkyl, (C1C13) heteroaryl, and a counter ion; and where R14 and R15 are independently selected from the group consisting of H, substituted and unsubstituted (C1-C20) alkyl, (C2-C20) alkenyl and (C5-C14) aryl; the other substituents are defined in the claims.</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20140527&amp;DB=EPODOC&amp;CC=CA&amp;NR=2598087C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20140527&amp;DB=EPODOC&amp;CC=CA&amp;NR=2598087C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>AGARWAL, SHIV KUMAR</creatorcontrib><creatorcontrib>BADIGER, SANGAMESH</creatorcontrib><creatorcontrib>NAG, ABHIJEET</creatorcontrib><creatorcontrib>NEOGI, PARTHA</creatorcontrib><creatorcontrib>NAG, BISHWAJIT</creatorcontrib><creatorcontrib>DEY, DEBENDRANATH</creatorcontrib><creatorcontrib>REDDY, GADDAM OM</creatorcontrib><creatorcontrib>PANDEY, SURENDRA KUMAR</creatorcontrib><creatorcontrib>SINGH, GAJENDRA</creatorcontrib><creatorcontrib>CHITHRA, SANTHANAGOPALAN</creatorcontrib><title>5-[4-(4-(2-AMINO-2 METHOXYCARBONYLETHYL)PHENOXY)BENZILIDENE]THIAZOLIDIN-2,4-DIONE DERIVATIVES AND RELATED COMPOUNDS FOR REDUCING GLUCOSE, CHOLESTEROL AND TRIGLYCERIDE LEVELS IN PLASMA</title><description>Diphenyl ether compounds of the formula (I) are provided th-it exhibit activity useful for reducing glucose, cholesterol, and/or triglyceride levels in plasma, and for treatment of obesity, inflammation, immunological diseases, autoimmune diseases, diabetes and disorders associated with insulin resistance. (I) wherein represents an optional bond; W represents O or S; Z represents CR10, O or S; G represents O, S or together with R10 forms a 5 or 6 membered aromatic or heteroaromatic ring system containing 1 or 2 heteroatoms selected from the group consisting of O, S and N; R8 represents OR13 or NR14R15; where R13 is selected from the group consisting of hydrogen, substituted and unsubstituted (C1-C20) alkyl, (C2-C20) alkenyl, (C5-C14) aryl, (C6-C34) aralkyl, (C1C13) heteroaryl, and a counter ion; and where R14 and R15 are independently selected from the group consisting of H, substituted and unsubstituted (C1-C20) alkyl, (C2-C20) alkenyl and (C5-C14) aryl; the other substituents are defined in the claims.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFjMFKA0EQRPfiQdRvsI8GMiBrQpLjZKaz29DbvczMLtmIhCDjSTQQ_83fcxDvQkFRj6q6rr6X5nlhHopqYzsSNTV0mFrdT86GrcrEJU0861uUAmdblAMxeRR8SS3Zg5ZAYur5wnhSQfAYaLSJRoxgxUNAtgk9OO16HcRH2Gko1A-OpIGGB6cR5-BaZYwJg_LvLgVqeHLlzSMwjsgRSKBnGzt7W129nd4v-e7Pb6r7HSbXmnz-PObL-fSaP_LX0dl6uVk_rlfu6f_GD43mSkQ</recordid><startdate>20140527</startdate><enddate>20140527</enddate><creator>AGARWAL, SHIV KUMAR</creator><creator>BADIGER, SANGAMESH</creator><creator>NAG, ABHIJEET</creator><creator>NEOGI, PARTHA</creator><creator>NAG, BISHWAJIT</creator><creator>DEY, DEBENDRANATH</creator><creator>REDDY, GADDAM OM</creator><creator>PANDEY, SURENDRA KUMAR</creator><creator>SINGH, GAJENDRA</creator><creator>CHITHRA, SANTHANAGOPALAN</creator><scope>EVB</scope></search><sort><creationdate>20140527</creationdate><title>5-[4-(4-(2-AMINO-2 METHOXYCARBONYLETHYL)PHENOXY)BENZILIDENE]THIAZOLIDIN-2,4-DIONE DERIVATIVES AND RELATED COMPOUNDS FOR REDUCING GLUCOSE, CHOLESTEROL AND TRIGLYCERIDE LEVELS IN PLASMA</title><author>AGARWAL, SHIV KUMAR ; BADIGER, SANGAMESH ; NAG, ABHIJEET ; NEOGI, PARTHA ; NAG, BISHWAJIT ; DEY, DEBENDRANATH ; REDDY, GADDAM OM ; PANDEY, SURENDRA KUMAR ; SINGH, GAJENDRA ; CHITHRA, SANTHANAGOPALAN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2598087C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2014</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>AGARWAL, SHIV KUMAR</creatorcontrib><creatorcontrib>BADIGER, SANGAMESH</creatorcontrib><creatorcontrib>NAG, ABHIJEET</creatorcontrib><creatorcontrib>NEOGI, PARTHA</creatorcontrib><creatorcontrib>NAG, BISHWAJIT</creatorcontrib><creatorcontrib>DEY, DEBENDRANATH</creatorcontrib><creatorcontrib>REDDY, GADDAM OM</creatorcontrib><creatorcontrib>PANDEY, SURENDRA KUMAR</creatorcontrib><creatorcontrib>SINGH, GAJENDRA</creatorcontrib><creatorcontrib>CHITHRA, SANTHANAGOPALAN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>AGARWAL, SHIV KUMAR</au><au>BADIGER, SANGAMESH</au><au>NAG, ABHIJEET</au><au>NEOGI, PARTHA</au><au>NAG, BISHWAJIT</au><au>DEY, DEBENDRANATH</au><au>REDDY, GADDAM OM</au><au>PANDEY, SURENDRA KUMAR</au><au>SINGH, GAJENDRA</au><au>CHITHRA, SANTHANAGOPALAN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>5-[4-(4-(2-AMINO-2 METHOXYCARBONYLETHYL)PHENOXY)BENZILIDENE]THIAZOLIDIN-2,4-DIONE DERIVATIVES AND RELATED COMPOUNDS FOR REDUCING GLUCOSE, CHOLESTEROL AND TRIGLYCERIDE LEVELS IN PLASMA</title><date>2014-05-27</date><risdate>2014</risdate><abstract>Diphenyl ether compounds of the formula (I) are provided th-it exhibit activity useful for reducing glucose, cholesterol, and/or triglyceride levels in plasma, and for treatment of obesity, inflammation, immunological diseases, autoimmune diseases, diabetes and disorders associated with insulin resistance. (I) wherein represents an optional bond; W represents O or S; Z represents CR10, O or S; G represents O, S or together with R10 forms a 5 or 6 membered aromatic or heteroaromatic ring system containing 1 or 2 heteroatoms selected from the group consisting of O, S and N; R8 represents OR13 or NR14R15; where R13 is selected from the group consisting of hydrogen, substituted and unsubstituted (C1-C20) alkyl, (C2-C20) alkenyl, (C5-C14) aryl, (C6-C34) aralkyl, (C1C13) heteroaryl, and a counter ion; and where R14 and R15 are independently selected from the group consisting of H, substituted and unsubstituted (C1-C20) alkyl, (C2-C20) alkenyl and (C5-C14) aryl; the other substituents are defined in the claims.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_CA2598087C
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title 5-[4-(4-(2-AMINO-2 METHOXYCARBONYLETHYL)PHENOXY)BENZILIDENE]THIAZOLIDIN-2,4-DIONE DERIVATIVES AND RELATED COMPOUNDS FOR REDUCING GLUCOSE, CHOLESTEROL AND TRIGLYCERIDE LEVELS IN PLASMA
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T06%3A01%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=AGARWAL,%20SHIV%20KUMAR&rft.date=2014-05-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2598087C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true